SPY316.18+2.40 0.76%
DIA260.72+1.68 0.65%
IXIC10,492.50+148.61 1.44%

Aileron Therapeutics Earlier Reported Q3 EPS $(0.28) Misses $(0.23) Estimate

Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.23) by 21.74 percent. This is a 44 percent increase over losses of $(0.5) per share

Benzinga · -

Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.23) by 21.74 percent. This is a 44 percent increase over losses of $(0.5) per share from the same period last year.